New Blog Coming Soon! – deals are closing!

Just a reminder that we are looking to make changes to our blog, but want to update on deals that closed!

Healthcare is alive and well!  Here are few recent closing!

eGenesis, a biotechnology company focused on utilizing genome editing technology in medical procedures, raised a $38 million in Series A funding. Biomatics Capital and ARCH Venture Partners led the round, with participation from Khosla Ventures, Alta Partners, Alexandria Venture Investments, Heritage Provider Network, Berggruen Holdings North America, Uprising, and Fan Ventures.

Peloton Therapeutics, a Dallas drug discovery and development company, raised $22.2 million in additional Series D funding, closing the round at $74.6 million.

908 Devices, a Boston developer of analytical devices for chemical and biomolecule analysis, raised $20 million in funding. Investors include Tao Capital Partners, Cormorant Asset Management, Saudi Aramco Energy Ventures, ARCH Venture Partners, Razor’s Edge Ventures, Schlumberger, and Casdin Capital.

NeuraLace, a San Diego, Calif. developer of non-opioid pain reduction treatment, raised $2 million in funding from FusionX Ventures.

Happy Networking and Investing,

JD Morris

JD Morris

https://www.linkedin.com/in/jdmorris

Author: JDM

Learn more about JDM Biography on LinkedIn: http://www.linkedin.com/in/jdmorris